Systematic review of interventions for mental health, cognition and psychological well-being in long COVID.

0 PSYCHIATRY
Lisa D Hawke, Anh T P Nguyen, Wei Wang, Eric E Brown, Dandan Xu, Susan Deuville, Suzie Goulding, Chantal F Ski, Susan L Rossell, David R Thompson, Terri Rodak, Gillian Strudwick, David Castle
{"title":"Systematic review of interventions for mental health, cognition and psychological well-being in long COVID.","authors":"Lisa D Hawke, Anh T P Nguyen, Wei Wang, Eric E Brown, Dandan Xu, Susan Deuville, Suzie Goulding, Chantal F Ski, Susan L Rossell, David R Thompson, Terri Rodak, Gillian Strudwick, David Castle","doi":"10.1136/bmjment-2024-301133","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>This systematic review aims to identify and synthesise the publicly available research testing treatments for mental health, cognition and psychological well-being in long COVID.</p><p><strong>Methods: </strong>The following databases and repositories were searched in October-November 2023: Medline, Embase, APA PsycINFO, Cumulative Index to Nursing and Allied Health Literature, China National Knowledge Internet, WANFANG Data, Web of Science's Preprint Citation Index, The Cochrane Central Register of Controlled Trials, Clinicaltrials.gov and the WHO International Clinical Trials Registry Platform. Articles were selected if they described participants with long COVID symptoms at least 4 weeks after SAR-CoV-19 infection, reported primary outcomes on mental health, cognition and/or psychological well-being, and were available with at least an English-language summary. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines for systematic reviews were followed.</p><p><strong>Results: </strong>Thirty-three documents representing 31 studies were included. Seven tested psychosocial interventions, five pharmaceutical interventions, three natural supplement interventions, nine neurocognitive interventions, two physical rehabilitation interventions and five integrated interventions. While some promising findings emerged from randomised controlled trials, many studies were uncontrolled; a high risk of bias and insufficient reporting were also frequent.</p><p><strong>Conclusions: </strong>The published literature on treatments for mental health, cognition and psychological well-being in long COVID show that the interventions are highly heterogeneous and findings are inconclusive to date. Continued scientific effort is required to improve the evidence base. Regular literature syntheses will be required to update and educate clinicians, scientists, interventionists and the long COVID community.</p>","PeriodicalId":72434,"journal":{"name":"BMJ mental health","volume":"27 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11474695/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ mental health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjment-2024-301133","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"0","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: This systematic review aims to identify and synthesise the publicly available research testing treatments for mental health, cognition and psychological well-being in long COVID.

Methods: The following databases and repositories were searched in October-November 2023: Medline, Embase, APA PsycINFO, Cumulative Index to Nursing and Allied Health Literature, China National Knowledge Internet, WANFANG Data, Web of Science's Preprint Citation Index, The Cochrane Central Register of Controlled Trials, Clinicaltrials.gov and the WHO International Clinical Trials Registry Platform. Articles were selected if they described participants with long COVID symptoms at least 4 weeks after SAR-CoV-19 infection, reported primary outcomes on mental health, cognition and/or psychological well-being, and were available with at least an English-language summary. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines for systematic reviews were followed.

Results: Thirty-three documents representing 31 studies were included. Seven tested psychosocial interventions, five pharmaceutical interventions, three natural supplement interventions, nine neurocognitive interventions, two physical rehabilitation interventions and five integrated interventions. While some promising findings emerged from randomised controlled trials, many studies were uncontrolled; a high risk of bias and insufficient reporting were also frequent.

Conclusions: The published literature on treatments for mental health, cognition and psychological well-being in long COVID show that the interventions are highly heterogeneous and findings are inconclusive to date. Continued scientific effort is required to improve the evidence base. Regular literature syntheses will be required to update and educate clinicians, scientists, interventionists and the long COVID community.

对长期 COVID 的精神健康、认知和心理健康干预措施进行系统回顾。
目的:本系统性综述旨在确定和综合公开可用的研究成果,这些成果测试了针对长期慢性病人的精神健康、认知和心理健康的治疗方法:方法:2023 年 10 月至 11 月期间,对以下数据库和资料库进行了检索:Medline, Embase, APA PsycINFO, Cumulative Index to Nursing and Allied Health Literature, China National Knowledge Internet, WANFANG Data, Web of Science's Preprint Citation Index, The Cochrane Central Register of Controlled Trials, Clinicaltrials.gov and the WHO International Clinical Trials Registry Platform。如果文章描述了参与者在感染 SAR-CoV-19 后至少 4 周内出现的长期 COVID 症状,报告了精神健康、认知和/或心理健康方面的主要结果,并且至少提供了英文摘要,则入选。研究遵循了《系统综述和元分析首选报告项目》(Preferred Reporting Items for Systematic Reviews and Meta-Analyses)的系统综述指南:纳入了代表 31 项研究的 33 份文件。其中七项测试了社会心理干预,五项测试了药物干预,三项测试了天然补充剂干预,九项测试了神经认知干预,两项测试了身体康复干预,五项测试了综合干预。虽然随机对照试验得出了一些有希望的结果,但许多研究都是非对照的;偏倚风险高和报告不充分的情况也很常见:已发表的有关长期慢性阻塞性肺病患者精神健康、认知和心理健康治疗的文献表明,这些干预措施存在很大差异,迄今为止还没有定论。需要继续开展科学研究,以完善证据基础。需要定期进行文献综述,以更新并教育临床医生、科学家、干预专家和长期慢性阻塞性肺病患者群体。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.80
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信